Based on my understanding of the subject, this information from RNS will assist in escalating the approval process.
“ The Genedrive SARS-CoV-2 POC Kit follows a similar workflow that has already been validated in the Company's Genedrive® HCV-ID Kit which received WHO pre-qualification earlier this year”.
I think in coming weeks we will see good upward trend based on this development.
Sorry not 100% sure about that, he (MOIL) has been posting some decent news lately on Twitter forums, however personally I believe the information reflects the ground realities when I compared the data.